Search Login Register

Atherosclerosis Summary

Description: A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.

Also Known As: Atheroscleroses; Atherogenesis

Networked: 44084 relevant articles (1465 outcomes, 6951 trials/studies) for this Disease

Key Drugs and Agents for Atherosclerosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Cholesterol : 183 outcomes 620 studies in 5380 results : IBA
  2. Lipoproteins (Lipoprotein) : 98 outcomes 488 studies in 4638 results : IBA
  3. Apolipoproteins E (ApoE) : 84 outcomes 376 studies in 2134 results : IBA
  4. Apolipoproteins : 55 outcomes 291 studies in 1863 results : IBA
  5. Insulin (Novolin) : 34 outcomes 148 studies in 850 results : FDA 2
  6. Apolipoprotein A-I (Apolipoprotein A1) : 31 outcomes 76 studies in 463 results : IBA
  7. Lipids : 30 outcomes 179 studies in 1539 results : IBA
  8. Estrogens (Estrogen) : 30 outcomes 108 studies in 426 results : FDA 1
  9. Biological Markers (Surrogate Marker) : 28 outcomes 212 studies in 970 results : IBA
  10. LDL Receptors (LDL Receptor) : 28 outcomes 108 studies in 735 results : IBA
Show All >>

Diseases Related to Atherosclerosis

  1. Inflammation
  2. Hypertension (High Blood Pressure)
  3. Cardiovascular Diseases (Cardiovascular Disease)
  4. Hypercholesterolemia
  5. Hyperlipidemias (Hyperlipidemia)
Show All >>

Key Therapies for Atherosclerosis

Efficacy Chart >>
  1. Transplants (Transplant) : 24 outcomes 111 studies in 1109 results
  2. Angioplasty (Angioplasty, Transluminal) : 18 outcomes 31 studies in 462 results
  3. Stents : 13 outcomes 23 studies in 227 results
  4. Hormone Replacement Therapy (Therapy, Hormone Replacement) : 8 outcomes 28 studies in 74 results
  5. Coronary Artery Bypass (Coronary Artery Bypass Surgery) : 6 outcomes 33 studies in 204 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.